GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

Search

Mirion Technologies Inc

Suletud

SektorTööstus

19.93 0.81

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

19.67

Max

20.12

Põhinäitajad

By Trading Economics

Sissetulek

-16M

400K

Müük

-52M

202M

Aktsiakasum

0.1

Kasumimarginaal

0.198

Töötajad

2,800

EBITDA

135M

47M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

-9.04% downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

31. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

875M

4.4B

Eelmine avamishind

19.12

Eelmine sulgemishind

19.93

Uudiste sentiment

By Acuity

50%

50%

192 / 464 Pingereas Industrials

Mirion Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. mai 2025, 14:40 UTC

Suurimad hinnamuutused turgudel

Mirion Technologies Shares Rise After Upsized Notes Offering Prices

Võrdlus sarnastega

Hinnamuutus

Mirion Technologies Inc Prognoos

Hinnasiht

By TipRanks

-9.04% langus

12 kuu keskmine prognoos

Keskmine 18 USD  -9.04%

Kõrge 20 USD

Madal 17 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Mirion Technologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

192 / 464 Pingereas Tööstus

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Mirion Technologies Inc

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.